has a solid resume and focuses on medical-technology stocks. Meanwhile, well-credentialed managers Rebecca Sykes (who focuses on pharmaceutical names), Wen Shi (who concentrates on biotech stocks ...

Much has been written about the demise of the traditional pharmaceutical sales model and the “Complex ... ecosystem of information sources. For example, The National Institute for Health and ...

While pharmaceutical sales in many mature markets are showing stagnant growth or even regressions, the sales estimates in the emerging markets point to continued growth. In fact, it is estimated ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., March 27, 2025. REUTERS/Brendan McDermid A rocky U.S. stock market will be tested in the coming week by a ...

BEDFORD, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue ...

For example ... and Anolic had extensive resumes before joining forces. Weiner had significant experience with tech and biotech stocks, while Anolic had extensive pharmaceutical coverage.

Americans pay far more for GLP-1 drugs than citizens in other wealthy nations. If Dr. Marty Makary, the new FDA commissioner, ...